What is the most appropriate next step in evaluation and management for a 68-year-old man with a 7‑week history of mid‑thoracic back pain radiating to the umbilicus, worsened by movement and at night, anemia (hemoglobin 8 g/dL) and mild hypercalcemia (serum calcium 10.8 mg/dL)?

Immediate Imaging and Hematologic Workup for Suspected Multiple Myeloma

This patient requires urgent spine imaging (MRI preferred, or CT if MRI unavailable) and immediate hematologic evaluation including serum protein electrophoresis (SPEP), urine protein electrophoresis (UPEP), serum free light chains, and bone marrow biopsy to diagnose multiple myeloma.

Clinical Reasoning

This presentation screams multiple myeloma with classic red flags that demand immediate action:

• Age 68 years (peak incidence for MM)
• Persistent back pain >7 weeks with nocturnal worsening (suggests pathologic process, not mechanical)
• Mid-thoracic pain radiating to umbilicus (dermatomal pattern suggesting nerve root involvement or vertebral pathology)
• Anemia (Hgb 8 g/dL) - severe and unexplained
• Hypercalcemia (10.8 mg/dL) - mild but significant in this context
• Pain worse with movement and at night (classic for malignant bone disease)

The combination of anemia and hypercalcemia in an elderly patient with vertebral pain is pathognomonic for multiple myeloma until proven otherwise 1. These findings should never be dismissed as benign, especially when occurring together 1.

Immediate Diagnostic Steps

1. Spine Imaging - URGENT

• MRI of entire spine is the gold standard to evaluate for:
  • Vertebral compression fractures
  • Epidural compression/cord involvement
  • Lytic bone lesions
  • Impending pathologic fractures
• If MRI unavailable or contraindicated, obtain CT spine immediately
• This cannot wait - spinal cord compression is an oncologic emergency

2. Complete Hematologic Workup

• Serum protein electrophoresis (SPEP) with immunofixation
• Urine protein electrophoresis (UPEP) with immunofixation (24-hour collection)
• Serum free light chain assay (kappa/lambda ratio)
• Complete blood count with differential
• Comprehensive metabolic panel including creatinine (assess renal function)
• Beta-2 microglobulin and LDH (prognostic markers)
• Quantitative immunoglobulins (IgG, IgA, IgM)

3. Bone Marrow Biopsy

• Essential for definitive diagnosis
• Looking for >10% clonal plasma cells
• Should be performed urgently once MM is suspected

Immediate Management Considerations

Hypercalcemia Treatment

The NCCN guidelines recommend treating hypercalcemia with 2:

• Aggressive IV hydration (normal saline)
• IV bisphosphonates - zoledronic acid is preferred by NCCN for hypercalcemia treatment 2
• Steroids (dexamethasone) - dual benefit for hypercalcemia and MM treatment
• Consider calcitonin for rapid effect if symptomatic

While this patient has only mild hypercalcemia (10.8 mg/dL), in the context of suspected malignancy with anemia, treatment should be initiated 3. Severe hypercalcemia is associated with significantly increased mortality 4, 5.

Anemia Management

• Type and screen BEFORE any daratumumab if MM is confirmed (daratumumab interferes with cross-matching) 2
• Consider transfusion if symptomatic or Hgb continues to drop
• Erythropoietin therapy may be considered, especially if renal dysfunction develops 2

Pain Management and Skeletal Complications

If MM is confirmed with vertebral involvement 2:

• Low-dose radiation therapy (8-30 Gy) for uncontrolled pain or impending fracture
• Orthopedic consultation for impending fractures in weight-bearing bones or spinal instability
• Vertebroplasty or kyphoplasty for symptomatic vertebral compression fractures
• Bone-modifying agents (bisphosphonates or denosumab) should be started immediately once MM diagnosis is confirmed 2

Critical Pitfalls to Avoid

1. Do NOT dismiss mild hypercalcemia and anemia as coincidental - this combination in an elderly patient with bone pain is multiple myeloma until proven otherwise 1

2. Do NOT delay imaging - spinal cord compression can develop rapidly and cause permanent neurologic damage. The nocturnal pain and movement-related worsening suggest structural instability 6

3. Do NOT order only plain radiographs - they miss 30-50% of lytic lesions. MRI or CT is mandatory 2

4. Do NOT forget to type and screen before daratumumab - this antibody-based therapy interferes with blood bank testing 2

5. Do NOT attribute anemia solely to "chronic disease" without full workup - in MM, anemia is multifactorial (marrow infiltration, renal dysfunction, cytokine effects) 2

Risk Stratification

This patient has multiple independent mortality risk factors if MM is confirmed 4, 5:

• Male sex
• Malignancy-associated hypercalcemia
• Severe anemia (Hgb 8 g/dL)
• Age >65 years

Mortality in malignancy-associated hypercalcemia is significantly higher than other causes, making rapid diagnosis and treatment initiation critical 5.

Timeline for Action

• Within 24 hours: Spine imaging, complete laboratory workup, IV hydration initiation
• Within 48-72 hours: Hematology consultation, bone marrow biopsy scheduling
• Within 1 week: Definitive diagnosis and treatment plan initiation

The 7-week duration of symptoms means this patient has already waited too long. Every additional day risks irreversible complications including spinal cord compression, pathologic fractures, and renal failure.